These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24969896)

  • 21. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
    Khalaf M; Abdel-Nabi H; Baker J; Shao Y; Lamonica D; Gona J
    J Hematol Oncol; 2008 Sep; 1():13. PubMed ID: 18808716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease.
    Huang YE; Lu HI; Liu FY; Huang YJ; Lin MC; Chen CF; Wang PW
    J Radiat Res; 2012; 53(2):306-12. PubMed ID: 22374400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT.
    Ohno Y; Koyama H; Matsumoto K; Onishi Y; Takenaka D; Fujisawa Y; Yoshikawa T; Konishi M; Maniwa Y; Nishimura Y; Ito T; Sugimura K
    Radiology; 2011 Feb; 258(2):599-609. PubMed ID: 21273522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
    Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
    Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
    Baba S; Isoda T; Maruoka Y; Kitamura Y; Sasaki M; Yoshida T; Honda H
    J Nucl Med; 2014 May; 55(5):736-42. PubMed ID: 24665089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?
    Regier M; Derlin T; Schwarz D; Laqmani A; Henes FO; Groth M; Buhk JH; Kooijman H; Adam G
    Eur J Radiol; 2012 Oct; 81(10):2913-8. PubMed ID: 22197090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Performance of Diffusion-Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation.
    Usuda K; Maeda S; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Watanabe N; Tonami H; Ueda Y; Sagawa M
    Asian Pac J Cancer Prev; 2015; 16(15):6401-6. PubMed ID: 26434850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease-endemic region.
    Henz Concatto N; Watte G; Marchiori E; Irion K; Felicetti JC; Camargo JJ; Hochhegger B
    Eur Radiol; 2016 Sep; 26(9):2915-20. PubMed ID: 26638164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of free-breathing radial 3D fat-suppressed T1-weighted gradient-echo sequence with diffusion weighted images: Potential for differentiating malignant from benign peripheral solid pulmonary masses.
    Dang S; Gao X; Ma G; Yu N; Han D; Yang Q; Tian X; Duan H
    Magn Reson Imaging; 2019 Apr; 57():271-276. PubMed ID: 30557591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
    Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
    Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer.
    Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Kuginuki Y; Taniguchi M; Ueda Y; Sakuma T
    Ann Surg Oncol; 2013 May; 20(5):1676-83. PubMed ID: 23242821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    Ann Thorac Surg; 2005 Mar; 79(3):984-8; discussion 989. PubMed ID: 15734419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
    Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
    Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
    Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
    Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Sugimura K
    AJR Am J Roentgenol; 2012 Jan; 198(1):75-82. PubMed ID: 22194481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.